article thumbnail

AstraZeneca’s Challenge to Price Negotiation Fails in Federal District Court

FDA Law Blog

AstraZeneca also claimed that CMS’s revised guidance on the Negotiation Program for Price Applicability Year 2026 (“Guidance”) interpreted the IRA in two very faulty ways, which violated the Administrative Procedure Act (APA) and harmed and will continue to harm the company. Opinion at 17. see also 42 U.S.C. 1320f-1(e)(1)(A).

article thumbnail

CDC, FDA Warn of Salmonella Outbreak Linked to Pistachio Cream

Physician's Weekly

Four individuals across two states have contracted the same strain of Salmonella. 19, 2026 (production code: 241019) and to thoroughly disinfect items and surfaces that may have come in contact with the product. The FDA is currently determining whether this lot is in distribution and if other lots or products are affected.

Illness 40